Hello,
Welcome to
- Meet this year's 30 leaders under 40 transforming healthcare;
- United Health Group's Optum is wading into the direct-to-consumer world;
- Moderna's CEO spelled out his M&A strategy and what the company is looking for in gene editing.
If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...
Meet the 30 young leaders forging a new future for the healthcare industry in 2021
- A generation of leaders is transforming the healthcare industry.
- They include doctors, scientists, execs, and founders who are improving how we keep people healthy.
- Out of hundreds of nominations, Insider selected 30 leaders under 40 transforming healthcare.
The biggest US healthcare company is jumping into the red-hot direct-to-consumer prescription market
- Industry giant UnitedHealth Group is pushing into the direct-to-consumer healthcare market.
- The company's Optum business is selling generic drugs and virtual care to people who pay with cash.
- The move brings new competition to digital-health upstarts such as Ro and Hims.
Moderna's CEO spells out its new M&A strategy, including what the $160 billion biotech is looking for in gene editing
- Thinking beyond COVID-19, Moderna is planning to get into the gene therapy and editing space.
- CEO Stephane Bancel said he'd like to license in new enzymes to use in gene editing.
- A full acquisition of a gene-editing company is unlikely, he said, because of the rich valuations.
More stories we're reading:
- The CEO of the anti-aging foundation cofounded by Aubrey de Grey left amid an investigation into sexual harassment allegations against de Grey (Stat News)
- Rates of children hospitalized with COVID-19 have reached an all-time high in the US (Insider)
- What happens when algorithms get involved with opioid prescribing (Wired)
- How one woman overcame her vaccine hesitancy: 'You call them anti-vaxxers - I believe a lot of them are just afraid' (Insider)
- Lydia